Macrosporin (CAS 22225-67-8)

Macrosporin, an anthraquinone-derived polyketide antibiotic produced by Streptomyces bacteria, is known for its significant antibacterial capabilities, particularly against Bacillus subtilis and Staphylococcus aureus. Identified in 1995, it belongs to the vast family of polyketides, recognized for their antimicrobial prowess against a diverse array of microorganisms, including Gram-positive and Gram-negative bacteria, fungi, and viruses. Beyond its antimicrobial action, Macrosporin also exhibits immunomodulatory and anti-inflammatory effects. It has been utilized in scientific research to delve into the physiology and pathogenesis of bacteria and fungi, immune system functioning, drug resistance mechanisms, and the biology of cancer cells, highlighting its anti-tumor potential. The exact mechanism through which Macrosporin exerts its effects is not fully elucidated but is thought to involve the disruption of cell wall synthesis in microbial cells and the inhibition of toxin production and virulence factors. Additionally, its role in modulating immune responses indicates its versatile potential in scientific exploration and the promise it holds for future investigative and developmental efforts.